Silence Therapeutics PLC
NASDAQ:SLN

Watchlist Manager
Silence Therapeutics PLC Logo
Silence Therapeutics PLC
NASDAQ:SLN
Watchlist
Price: 6.2 USD 0.98% Market Closed
Market Cap: 289.3m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of SLN.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SLN Intrinsic Value
Not Available
Base Case Scenario
Compare SLN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SLNCF?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Silence Therapeutics PLC

Balance Sheet Decomposition
Silence Therapeutics PLC

Current Assets 90.7m
Cash & Short-Term Investments 50.3m
Receivables 38.3m
Other Current Assets 2.1m
Non-Current Assets 9.4m
Long-Term Investments 293k
PP&E 832k
Intangibles 28k
Other Non-Current Assets 8.2m
Current Liabilities 9.2m
Other Current Liabilities 9.2m
Non-Current Liabilities 63.2m
Other Non-Current Liabilities 63.2m
Efficiency

Free Cash Flow Analysis
Silence Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Silence Therapeutics PLC

Revenue
1.4m GBP
Operating Expenses
-28.6m GBP
Operating Income
-27.2m GBP
Other Expenses
4.8m GBP
Net Income
-22.4m GBP
Fundamental Scores

SLN Profitability Score
Profitability Due Diligence

Silence Therapeutics PLC's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

Silence Therapeutics PLC's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

SLN Solvency Score
Solvency Due Diligence

Silence Therapeutics PLC's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Low D/E
Long-Term Solvency
74/100
Solvency
Score

Silence Therapeutics PLC's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SLN Price Targets Summary
Silence Therapeutics PLC

There are no price targets for SLN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Silence Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for SLNCF is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y